Skip to main content
Spin-off

Bac3Gel LDA

Year of incorporation

2020

Field

Biotech & Life science.

Activity

Bac3Gel provides Pharma and Biotech with high throughput in vitro preclinical models that optimise the development of antimicrobial agents, probiotics, prebiotics and other food integrators. Bac3Gel technological platform enables the production of 3D universal substrates to culture, transport, preserve and deliver bacteria.

Services

Distribution of in vitro preclinical models and consultancy services for pharma and biotech that develop antimicrobial agents, pre- and probiotics and other food integrators.

Target Market

Drug Development and microbiome.

Website

www.bac3gel.com